Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Rosen, M. I. Articles by Rosenheck, R. Search for Related Content PubMed Citation Articles by Rosen, M. I. Articles by Rosenheck, R. Dual Diagnosis Patients Social Security, Other Entitlements Addictive Disorders (General)

Substance Use and Assignment of Representative Payees

Recent legislation prohibiting the awarding of Social Security Disability Insurance benefits to people whose disability is based on drug and alcohol abuse has effectively eliminated the Social Security Administration's practice of assigning representative payees to such persons. Currently no regulations exist for assigning representative payees to substance users who receive benefits based on non-substance-use disabilities. The authors suggest guidelines for determining when recipients with comorbid substance use disorders are incapable of managing their benefit funds. Representative payeeship is recommended for recipients who meet three criteria within the last 12 months: a maladaptive pattern of substance use; mismanagement of funds due to substance use, causing substantial harm to the recipient, unavailability of sufficient funds to meet basic needs, or victimization of the recipient; and availability of a representative payee whose efforts would increase the likelihood that the beneficiary's mismanagement of funds will be curtailed.

This article has been cited by other articles:

				B. Angell, N. I. Martinez, C. A. Mahoney, and P. W. Corrigan Payeeship, Financial Leverage, and the Client-Provider Relationship Psychiatr Serv, March 1, 2007; 58(3): 365 - 372. [Abstract] [Full Text] [PDF]

				D. C Marson, R. Savage, and J. Phillips Financial Capacity in Persons with Schizophrenia and Serious Mental Illness: Clinical and Research Ethics Aspects Schizophr Bull, January 1, 2006; 32(1): 81 - 91. [Abstract] [Full Text] [PDF]

				E. B. Elbogen, C. Soriano, R. V. Dorn, M. S. Swartz, and J. W. Swanson Consumer Views of Representative Payee Use of Disability Funds to Leverage Treatment Adherence Psychiatr Serv, January 1, 2005; 56(1): 45 - 49. [Abstract] [Full Text] [PDF]

				R. A. Rosenheck and M. S. Neale Therapeutic Limit Setting and Six-Month Outcomes in a Veterans Affairs Assertive Community Treatment Program Psychiatr Serv, February 1, 2004; 55(2): 139 - 144. [Abstract] [Full Text] [PDF]

				E. B. Elbogen, J. W. Swanson, M. S. Swartz, and H. R. Wagner Characteristics of Third-Party Money Management for Persons With Psychiatric Disabilities Psychiatr Serv, August 1, 2003; 54(8): 1136 - 1141. [Abstract] [Full Text] [PDF]

				M. I. Rosen, R. A. Rosenheck, A. Shaner, T. Eckman, G. Gamache, and C. Krebs Veterans Who May Need a Payee to Prevent Misuse of Funds for Drugs Psychiatr Serv, August 1, 2002; 53(8): 995 - 1000. [Abstract] [Full Text] [PDF]

				P. Hanrahan, D. J. Luchins, C. Savage, G. Patrick, D. Roberts, and K. J. Conrad Representative Payee Programs for Persons With Mental Illness in Illinois Psychiatr Serv, February 1, 2002; 53(2): 190 - 194. [Abstract] [Full Text] [PDF]

				J. Monahan, R. J. Bonnie, P. S. Appelbaum, P. S. Hyde, H. J. Steadman, and M. S. Swartz Mandated Community Treatment: Beyond Outpatient Commitment Psychiatr Serv, September 1, 2001; 52(9): 1198 - 1205. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 1999 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us